Shing‐Jong Lin

2.1k total citations · 1 hit paper
67 papers, 1.5k citations indexed

About

Shing‐Jong Lin is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Shing‐Jong Lin has authored 67 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Shing‐Jong Lin's work include Angiogenesis and VEGF in Cancer (7 papers), Blood Pressure and Hypertension Studies (6 papers) and Nitric Oxide and Endothelin Effects (5 papers). Shing‐Jong Lin is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Blood Pressure and Hypertension Studies (6 papers) and Nitric Oxide and Endothelin Effects (5 papers). Shing‐Jong Lin collaborates with scholars based in Taiwan, United States and Brazil. Shing‐Jong Lin's co-authors include Tse‐Min Lu, Jaw‐Wen Chen, Hsin‐Bang Leu, Shao‐Sung Huang, Min‐Ji Charng, Po‐Hsun Huang, Ying‐Hwa Chen, Tao‐Cheng Wu, Chin‐Chou Huang and Pai‐Feng Hsu and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Annals of Neurology.

In The Last Decade

Shing‐Jong Lin

64 papers receiving 1.4k citations

Hit Papers

Systemic immune‐inflammation index (SII) predicted clinic... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shing‐Jong Lin Taiwan 21 539 324 306 297 192 67 1.5k
Chin‐Chou Huang Taiwan 21 549 1.0× 356 1.1× 327 1.1× 333 1.1× 211 1.1× 77 1.7k
Hongwei Zhao China 22 523 1.0× 437 1.3× 365 1.2× 189 0.6× 262 1.4× 121 1.9k
Clinton D. Kemp United States 21 396 0.7× 206 0.6× 639 2.1× 205 0.7× 268 1.4× 33 1.7k
Pedro Moreno Spain 18 446 0.8× 494 1.5× 373 1.2× 106 0.4× 398 2.1× 77 1.7k
Stefan Greisenegger Austria 21 410 0.8× 640 2.0× 179 0.6× 348 1.2× 152 0.8× 43 1.5k
Georges Khoueiry United States 14 328 0.6× 264 0.8× 207 0.7× 455 1.5× 123 0.6× 32 1.2k
Michael Fritzenwanger Germany 24 579 1.1× 260 0.8× 529 1.7× 199 0.7× 265 1.4× 73 1.6k
Karen Douglas United Kingdom 30 495 0.9× 258 0.8× 215 0.7× 203 0.7× 317 1.7× 69 2.7k
Rui Hu China 19 300 0.6× 193 0.6× 234 0.8× 121 0.4× 331 1.7× 92 1.4k
Nicola Cosentino Italy 25 937 1.7× 183 0.6× 552 1.8× 129 0.4× 195 1.0× 133 2.0k

Countries citing papers authored by Shing‐Jong Lin

Since Specialization
Citations

This map shows the geographic impact of Shing‐Jong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shing‐Jong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shing‐Jong Lin more than expected).

Fields of papers citing papers by Shing‐Jong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shing‐Jong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shing‐Jong Lin. The network helps show where Shing‐Jong Lin may publish in the future.

Co-authorship network of co-authors of Shing‐Jong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shing‐Jong Lin. A scholar is included among the top collaborators of Shing‐Jong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shing‐Jong Lin. Shing‐Jong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Yi, Chien‐Yi Hsu, Lingyun Cheng, et al.. (2025). Propafenone‐ vs . amiodarone‐associated adverse cardiac outcomes in patients with atrial fibrillation and heart failure. British Journal of Clinical Pharmacology. 91(9). 2567–2575.
2.
Chang, K H, Jing Lai, Shing‐Jong Lin, et al.. (2024). An Artificial Intelligence-assisted Diagnostic System Improves Upper Urine Tract Cytology Diagnosis. In Vivo. 38(6). 3016–3021. 1 indexed citations
3.
Chang, Ting‐Yung, Ruey‐Hsing Chou, Chun‐Chin Chang, et al.. (2022). Association of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Use With Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Patients With Stabilized Acute Myocardial Infarction: A Propensity Score Matching Study. Frontiers in Cardiovascular Medicine. 9. 882181–882181. 14 indexed citations
4.
Yang, Ya‐Ling, Cheng‐Hsueh Wu, Pai‐Feng Hsu, et al.. (2020). Systemic immune‐inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. European Journal of Clinical Investigation. 50(5). e13230–e13230. 455 indexed citations breakdown →
5.
Hsu, Hsiu-Chuan, Ying Liang, Ruey‐Hsing Chou, et al.. (2018). High health literacy is associated with less obesity and lower Framingham risk score: Sub-study of the VGH-HEALTHCARE trial. PLoS ONE. 13(3). e0194813–e0194813. 38 indexed citations
6.
Yang, Tsung‐Lin, et al.. (2017). TCTAP A-037 Aortic Arch Calcification Associated with Cardiovascular Events and Death Among Patients with Acute Coronary Syndrome. Journal of the American College of Cardiology. 69(16). S17–S19. 2 indexed citations
7.
Chang, Ting‐Ting, Tao‐Cheng Wu, Po‐Hsun Huang, et al.. (2016). Aliskiren directly improves endothelial progenitor cell function from Type II diabetic patients. European Journal of Clinical Investigation. 46(6). 544–554. 9 indexed citations
8.
Huang, Chin‐Chou, Wan‐Leong Chan, Yu‐Chun Chen, et al.. (2013). The beneficial effects of statins in patients undergoing hemodialysis. International Journal of Cardiology. 168(4). 4155–4159. 11 indexed citations
9.
Jan, Sheng‐Ling, et al.. (2013). Plasma B-type natriuretic peptide study in children with severe enterovirus 71 infection: a pilot study. International Journal of Infectious Diseases. 17(12). e1166–e1171. 7 indexed citations
11.
Wang, Chao‐Hung, et al.. (2011). Assessment of mouse hind limb endothelial function by measuring femoral artery blood flow responses. Journal of Vascular Surgery. 53(5). 1350–1358. 9 indexed citations
12.
Chen, Chun‐Chen, Shiow‐Wen Liou, Chi‐Chih Chen, et al.. (2011). Coenzyme Q10 Reduces Ethanol-Induced Apoptosis in Corneal Fibroblasts. PLoS ONE. 6(4). e19111–e19111. 29 indexed citations
13.
Hsieh, Ching‐Lin, Wen‐Jin Cherng, Chun‐Chi Chen, et al.. (2011). Differentiation profile of peripheral blood-derived vascular progenitor cell predicts intimal hyperplasia after coronary stenting. Heart and Vessels. 27(1). 10–19. 11 indexed citations
14.
Jan, Sheng‐Ling, et al.. (2010). Effect of exercise on asymptomatic children with an isolated aberrant subclavian artery. Acta Cardiologica. 65(2). 231–237. 5 indexed citations
15.
Jan, Sheng‐Ling, Shing‐Jong Lin, Yun‐Ching Fu, et al.. (2009). Extracorporeal life support for treatment of children with enterovirus 71 infection-related cardiopulmonary failure. Intensive Care Medicine. 36(3). 520–527. 26 indexed citations
16.
Chung, Chih‐Ping, Hung‐Yi Hsu, A‐Ching Chao, et al.. (2009). Jugular Venous Reflux Affects Ocular Venous System in Transient Monocular Blindness. Cerebrovascular Diseases. 29(2). 122–129. 30 indexed citations
17.
Shih, Chun‐Ming, et al.. (2005). The interaction of selected semiconducting biomaterials with platelet‐rich plasma and whole blood. Journal of Biomedical Materials Research Part A. 74A(3). 325–337. 15 indexed citations
18.
Lu, Tse‐Min, Yu‐An Ding, Min‐Ji Charng, & Shing‐Jong Lin. (2003). Asymmetrical dimethylarginine: A novel risk factor for coronary artery disease. Clinical Cardiology. 26(10). 458–464. 65 indexed citations
20.
Lin, Shing‐Jong. (1996). Risk factors, endothelial cell turnover and lipid transport in atherogenesis.. PubMed. 58(5). 309–16. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026